Glucagon-like peptide-1 analogues for overweight or obese adults-Reference-Cited by-同舟云学术

Glucagon-like peptide-1 analogues for overweight or obese adults

Published:2022-09-08 Issue:9 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Madrid Eva¹²,Ocara Vargas Miranda¹,Contreras-Vera Catalina¹,Saldías Cristina¹,Escobar Liquitay Camila Micaela³,Novik A Victoria¹⁴,Munoz Sergio R⁵,Bracchiglione Javier¹²

Affiliation:

1. School of Medicine; Universidad de Valparaíso; Viña del Mar Chile

2. Interdisciplinary Centre for Health Studies (CIESAL); Universidad de Valparaíso; Viña del Mar Chile

3. Research Department; Instituto Universitario Hospital Italiano de Buenos Aires; Buenos Aires Argentina

4. School of Medicine; Universidad Andrés Bello; Viña del Mar Chile

5. Department of Public Health-CIGES; Faculty of Medicine, Universidad de La Frontera; Temuco Chile

Publisher

Wiley

Subject

Pharmacology (medical)

Reference54 articles.

1. Interaction revisited: the difference between two estimates;Altman;BMJ,2003

2. Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity;Anandhakrishnan;World Journal of Diabetes,2016

3. The ongoing nutrition transition thwarts long-term targets for food security, public health and environmental protection;Bodirsky;Scientific Reports,2020

4. Obesity medications: what does the future look like?;Butsch;Current Opinion in Endocrinology, Diabetes, and Obesity,2015

5. The medical care costs of obesity: an instrumental variables approach;Cawley;Journal of Health Economics,2012

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological treatments for adults with overweight and obesity without diabetes;Cochrane Database of Systematic Reviews;2024-04-18